Central administration of Neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice

Protein and Peptide Letters

Volumn 18, Issue 4, 2011, Pages 403-409

  Fang, Quan ^a   Jiang, Tian Nan ^a   Li, Ning ^a   Han, Zheng Lan ^a   Wang, Rui ^a,b  

^a LANZHOU UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Analgesia; Intraperitoneal (i.p.) injection; Mice; Morphine; Neuropeptide FF (NPFF); Receptor

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; NEUROPEPTIDE; NEUROPEPTIDE FF RECEPTOR; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE VF; OLIGOPEPTIDE; PHENYLALANYL LEUCYL PHENYLALANYL GLUTAMINYL PROLYL GLUTAMINYL ARGINYL PHENYLALANINAMIDE; PHENYLALANYL-LEUCYL-PHENYLALANYL-GLUTAMINYL-PROLYL-GLUTAMINYL-ARGINYL-PHENYLALANINAMIDE;

ANALGESIA; ANIMAL; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; MALE; MOUSE; MOUSE STRAIN; PAIN;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; NARCOTIC ANTAGONISTS; NEUROPEPTIDES; OLIGOPEPTIDES; PAIN; RECEPTORS, NEUROPEPTIDE;

MUS;

EID: 79951640928     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986611794654012     Document Type: Article

References (34)

1. Yang, H. Y.; Fratta, W.; Majane, E. A.; Costa, E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U. S. A., 1985, 82, 7757-7761. (Pubitemid 16204428)
2. Perry, S. J.; Yi-Kung Huang, E.; Cronk, D.; Bagust, J.; Sharma, R.; Walker, R. J.; Wilson, S.; Burke, J. F. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS. Lett., 1997, 409, 426-430. (Pubitemid 27285899)
3. Vilim, F. S.; Aarnisalo, A. A.; Nieminen, M. L.; Lintunen, M.; Karlstedt, K.; Kontinen, V. K.; Kalso, E.; States, B.; Panula, P.; Ziff, E. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol. Pharmacol., 1999, 55, 804-811. (Pubitemid 29214599)
4. Bonini, J. A.; Jones, K. A.; Adham, N.; Forray, C.; Artymyshyn, R.; Durkin, M. M.; Smith, K. E.; Tamm, J. A.; Boteju, L. W.; Lakhlani, P. P.; Raddatz, R.; Yao, W. J.; Ogozalek, K. L.; Boyle, N.; Kouranova, E. V.; Quan, Y.; Vaysse, P. J.; Wetzel, J. M.; Branchek, T. A.; Gerald, C.; Borowsky, B. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem., 2000, 275, 39324-39331. (Pubitemid 32058954)
5. Elshourbagy, N. A.; Ames, R. S.; Fitzgerald, L. R.; Foley, J. J.; Chambers, J. K.; Szekeres, P. G.; Evans, N. A.; Schmidt, D. B.; Buckley, P. T.; Dytko, G. M.; Murdock, P. R.; Milligan, G.; Groarke, D. A.; Tan, K. B.; Shabon, U.; Nuthulaganti, P.; Wang, D. Y.; Wilson, S.; Bergsma, D. J.; Sarau, H. M. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G proteincoupled receptor. J. Biol. Chem., 2000, 275, 25965-25971.
6. Hinuma, S.; Shintani, Y.; Fukusumi, S.; Iijima, N.; Matsumoto, Y.; Hosoya, M.; Fujii, R.; Watanabe, T.; Kikuchi, K.; Terao, Y.; Yano, T.; Yamamoto, T.; Kawamata, Y.; Habata, Y.; Asada, M.; Kitada, C.; Kurokawa, T.; Onda, H.; Nishimura, O.; Tanaka, M.; Ibata, Y.; Fujino, M. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat. Cell. Biol., 2000, 2, 703-708.
7. Liu, Q.; Guan, X. M.; Martin, W. J.; McDonald, T. P.; Clements, M. K.; Jiang, Q.; Zeng, Z.; Jacobson, M.; Williams, D. L., Jr. ; Yu, H.; Bomford, D.; Figueroa, D.; Mallee, J.; Wang, R.; Evans, J.; Gould, R.; Austin, C. P. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphineinduced antinociception. J. Biol. Chem., 2001, 276, 36961-36969.
8. Mollereau, C.; Mazarguil, H.; Marcus, D.; Quelven, I.; Kotani, M.; Lannoy, V.; Dumont, Y.; Quirion, R.; Detheux, M.; Parmentier, M.; Zajac, J. M. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur. J. Pharmacol., 2002, 451, 245-256. (Pubitemid 35254027)
9. Roussin, A.; Serre, F.; Gouarderes, C.; Mazarguil, H.; Roumy, M.; Mollereau, C.; Zajac, J. M. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. Biochem. Biophys. Res. Commun., 2005, 336, 197-203. (Pubitemid 41253421)
10. Gouarderes, C.; Mazarguil, H.; Mollereau, C.; Chartrel, N.; Leprince, J.; Vaudry, H.; Zajac, J. M. Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding. Neuropharmacology, 2007, 52, 376-386. (Pubitemid 46123357)
11. Yoshida, H.; Habata, Y.; Hosoya, M.; Kawamata, Y.; Kitada, C.; Hinuma, S., Molecular properties of endogenous RFamide-related peptide-3 and its interaction with receptors. Biochim. Biophys. Acta, 2003, 1593, 151-157. (Pubitemid 36173483)
12. Panula, P.; Aarnisalo, A. A.; Wasowicz, K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol., 1996, 48, 461-87.
13. Mollereau, C.; Roumy, M.; Zajac, J. M. Opioid-modulating peptides: mechanisms of action. Curr. Top. Med. Chem., 2005, 5, 341-355. (Pubitemid 40614134)
14. Rebeyrolles, S.; Zajac, J. M.; Roumy, M. Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones. Neuroreport, 1996, 7, 2979-2981. (Pubitemid 26426373)
15. Roumy, M.; Garnier, M.; Zajac, J. M. Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neurosci. Lett., 2003, 348, 159-162. (Pubitemid 36976830)
16. Mollereau, C.; Mazarguil, H.; Zajac, J. M.; Roumy, M. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol., 2005, 67, 965-975; (Pubitemid 40365344)
17. Kersante, F.; Mollereau, C.; Zajac, J. M.; Roumy, M. Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model. Peptides, 2006, 27, 980-989.
18. Gouarderes, C.; Zajac, J. M. Biochemical anti-opioid action of NPFF2 receptors in rat spinal cord. Neurosci. Res., 2007, 58, 91-94. (Pubitemid 46678491)
19. Gicquel, S.; Fioramonti, J.; Bueno, L.; Zajac, J. M. Effects of F8Famide analogs on intestinal transit in mice. Peptides, 1993, 14, 749-753;
20. Raffa, R. B.; Jacoby, H. I. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice. Peptides, 1989, 10, 873-875. (Pubitemid 19228506)
21. Gouarderes, C.; Quelven, I.; Mollereau, C.; Mazarguil, H.; Rice, S. Q.; Zajac, J. M. Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands. Neuroscience, 2002, 115, 349-361. (Pubitemid 35284753)
22. Quelven, I.; Roussin, A.; Zajac, J. M. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists. Eur. J. Pharmacol., 2005, 508, 107-114. (Pubitemid 40169908)
23. Fang, Q.; Li, N.; Jiang, T. N.; Liu, Q.; Li, Y. L.; Wang, R. Pressor and tachycardic responses to intrathecal administration of neuropeptide FF in anesthetized rats. Peptides, 2010 31, 683-688.
24. Haley TJ, M. W. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol., 1957, 12, 12-15.
25. Fang, Q.; Guo, J.; He, F.; Peng, Y. L.; Chang, M.; Wang, R. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptides, 2006, 27, 2207-2213. (Pubitemid 44189628)
26. Fang, Q.; He, F.; Wang, Y. Q.; Guo, J.; Zhang, B. Z.; Chen, Q.; Wang, R. Pharmacological effects of the dansylated neuropeptide FF analogues on body temperature and morphine analgesia. Neuropeptides, 2007, 41, 339-347. (Pubitemid 47247861)
27. Roumy, M.; Zajac, J. M. Neuropeptide FF, pain and analgesia. Eur. J. Pharmacol., 1998, 345, 1-11;
28. Panula, P.; Kalso, E.; Nieminen, M.; Kontinen, V. K.; Brandt, A.; Pertovaara, A. Neuropeptide FF and modulation of pain. Brain Res., 1999, 848, 191-196; (Pubitemid 30001668)
29. Yang, H. Y.; Tao, T.; Iadarola, M. J. Modulatory role of neuropeptide FF system in nociception and opiate analgesia. Neuropeptides, 2008, 42, 1-18. (Pubitemid 351187791)
30. Laurent, P.; Becker, J. A.; Valverde, O.; Ledent, C.; de Kerchove d'Exaerde, A.; Schiffmann, S. N.; Maldonado, R.; Vassart, G.; Parmentier, M. The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10. Nat. Neurosci., 2005, 8, 1735-1741. (Pubitemid 41683202)
31. Simonin, F.; Schmitt, M.; Laulin, J. P.; Laboureyras, E.; Jhamandas, J. H.; MacTavish, D.; Matifas, A.; Mollereau, C.; Laurent, P.; Parmentier, M.; Kieffer, B. L.; Bourguignon, J. J.; Simonnet, G. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 466-471; (Pubitemid 43122424)
32. Fang, Q.; Wang, Y. Q.; He, F.; Guo, J.; Guo, J.; Chen, Q.; Wang, R. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist. Regul. Pept., 2008, 147, 45-51.
33. Magnuson, D. S.; Sullivan, A. F.; Simonnet, G.; Roques, B. P.; Dickenson, A. H. Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord. Neuropeptides, 1990, 16, 213-218. (Pubitemid 20237185)
34. Roumy, M.; Lorenzo, C.; Mazeres, S.; Bouchet, S.; Zajac, J.M.; Mollereau, C. Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J. Biol. Chem., 2007, 282, 8332-8342. (Pubitemid 47093614)